Financial statements Midas Pharma Polska
Cash flow statement of Midas Pharma Polska
Company age:
Age:
20 y. 9 m. 6 d.
Share capital:
Share capital:
50 000 PLN
Cash inflows of MIDAS PHARMA POLSKA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | 908 122,53 | 905 768,37 | 2 317 663,84 | 2 360 465,58 | 2 783 103,96 | 987 818,78 |
| Net cash flow from investing activities | -1 865,85 | 0,00 | -146 345,61 | 15 721,74 | -4 025,00 | -110 680,75 |
| Net cash flow from financial activities | -669 796,88 | -1 088 020,14 | -2 521 175,21 | -81 766,46 | -85 583,90 | -2 076 921,46 |
| Total net cash flow | 236 459,80 | -182 251,77 | -349 856,98 | 2 294 420,86 | 2 693 495,06 | -1 199 783,43 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.